CASE STUDIES

Italian Blood Purification Equipment Partnership
Led an extensive market research project for an Italian blood purification company, identifying potential partnerships
and performing a comprehensive synergy assessment. Using tender and public databases, I analyzed the competitive landscape, engaging with representatives from companies producing both large and portable blood dialyzers. I defined market size opportunities for strategic partnerships and developed financial models to assess various scenarios. These models empowered the client to make informed decisions about potential partnerships, enabling them to optimize their market entry and growth strategy.

Cardiac Monitoring Device Market Entry Study in Australia
For this project, I conducted 30 interviews with medical doctors, distributors, field experts, and payers to gather
insights into the perception, potential adoption rates, price sensitivity, and reimbursement landscape for a novel pacemaker device in Australia. This comprehensive research provided critical data on market readiness and financial considerations, helping the client understand the competitive landscape and navigate regulatory and pricing challenges. The insights enabled a tailored go-to-market strategy, which ultimately supported the successful launch of the device in the Australian market.

Indication prioritization for a novel blood purification technology
I worked with a UK-based blood purification start-up to develop a comprehensive portfolio of medical indications
where blood purification could be applied. I started by conducting an extensive search across various medical fields to identify potential applications of blood purification technology, narrowing it down to five key areas. Next, I conducted 25 interviews with medical doctors (MDs) across five different geographies, focusing on understanding the molecular mechanisms of blood purification in each selected medical field.
Based on these insights, I assessed the business potential of each opportunity, evaluating factors such as market size, clinical need, cost-efficiency, reimbursement and innovation. After in-depth analysis and discussions with the client, we prioritized the three most promising indications. I then presented these findings to the client’s board, where I facilitated a discussion on the strategic direction, helping them make informed decisions about the company’s future product development and market focus.

Launch Excellence Playbook for an Israeli oncology startup
I was responsible for creating a comprehensive Launch Excellence Playbook for an Israeli oncology-focused medical
device company. The goal was to streamline the launch process and ensure that all global and regional teams were aligned and efficiently executing their tasks.
To achieve this, I conducted 40 interviews with key stakeholders from various departments, including R&D, regulatory, marketing, sales, and supply chain, spanned across Middle East, Europe, US and Asia to understand their specific needs and timelines. I then fine-tuned the launch-related tasks, responsibilities, and timing for 15 cross-functional teams, ensuring a coordinated and unified approach.
In addition, I structured and organized hundreds of activities across multiple teams and geographies, using an Excel-based tool that I developed to track progress, manage timelines, and ensure accountability. The tool became a central point for monitoring activities, enabling the client to manage the launch process with increased efficiency and visibility. This playbook and tool provided clear guidelines and ensured all teams worked toward common goals, greatly facilitating the smooth and timely product launch.

US Cardio-Pulmonary Market Landscape
I analyzed the US cardio-pulmonary medical devices market using a combination of open databases, secondary research,
and 25 expert interviews. Through this process, I identified the best regions and medical settings for sales opportunities, considering the competitive landscape, market trends, and customer needs.
I assessed factors such as regional demand, healthcare infrastructure, and the adoption of ECMO devices across different medical settings, such as hospitals of various sizes, non and academical, for profit and not-for-profit hospitals. By understanding the competitive environment, I was able to pinpoint high-potential areas and recommend targeted sales strategies that would enable the client to focus efforts on the most lucrative regions and medical settings, maximizing their market share and optimizing revenue growth.

Chromatography Equipment Portfolio Optimization
I worked on positioning the portfolio for a major German manufacturer of equipment used in industrial drug production.
My academic background and practical experience with such equipment made me well-suited to understand the technical aspects and industry-specific terminology, enabling effective communication with customers.
I conducted 30 interviews with key stakeholders across 10 regions, including pharmaceutical manufacturers, R&D labs, and production facilities. These discussions were focused on understanding customer needs, preferences, and challenges related to the equipment. Through these conversations, I gathered insights into performance expectations, operational issues, and market trends.
The findings helped identify critical product features, gaps in the market, and underserved segments. I also evaluated the competitive landscape and market dynamics. Using this information, I developed a portfolio strategy that better aligned with customer demands and strengthened the client’s market position, ultimately leading to improved customer satisfaction and increased demand.

Go-to-market strategy for a UK-based food start-up
I led the scientific segment of a project aimed at developing a go-to-market strategy for a novel UK-based cell-culture
food start-up. Our team evaluated various research approaches proposed by the client. I identified additional economic levers and innovative biological techniques to reduce costs, estimating their overall economic impact using publicly available data, expert interviews, and client team insights. This analysis resulted in a cost reduction of approximately 500 times, bringing the final product to a highly competitive price. Additionally, I helped identify key partners for critical processes, accelerating the product's market launch.

Partnership strategy for a big pharmaceutical MNC in Russia
I spearheaded the identification of field experts by collaborating with an outsourced search firm, conducting 20
interviews to benchmark partnership strategies for selected Rx drugs. I meticulously analyzed and structured the data, uncovering key patterns and establishing benchmarks that enabled the client to make informed strategic decisions. This actionable insight allowed the client to expand effectively in the Russian market, securing optimal partners for drug localization and ensuring sustainable growth in the region.

Due diligence on a medical devices business unit in Japan
Leveraging my expertise in the medical devices sector, I conducted a comprehensive due diligence on a business unit
for a major Japanese company, identifying key acquisition synergies and formulating a post-acquisition strategy. Through expert interviews, I performed market sizing for the target business, analyzed competitors' market shares across multiple regions, and developed financial models to assess various acquisition scenarios. My analysis provided the client with a clear understanding of how the acquisition would generate synergies and deliver long-term value.

Pharma Retail Location Optimization in Russia
I advised the client on optimal pharmacy locations, leveraging extensive data analysis to identify cost-saving
opportunities of approximately $3 million. By integrating internal sales data with external factors like foot traffic, I conducted advanced computational analysis (including clustering) in close collaboration with a team of analytics experts. This strategic approach enabled the client to make data-driven decisions, resulting in significant cost reductions.

Good-to-great business transformation of a steel-producing company in Russia
Over several months, I led a business transformation for one of Russia’s top steel producers, driving a G2G strategy.
I managed a client team of 20 onsite, supporting the PMO in executing a new management approach and implementing tools for a cultural shift. My efforts identified $30 million in revenue growth opportunities over three years, ensuring sustainable, long-term improvements for the company.

Organizational transformation of a metallurgical construction design company in Russia
As part of a team, I spearheaded the transformation of the organizational structure and management system for a